Announcements Trials

Browse Landscape

Phase

Phase NA 5 Phase 2 3 Phase 1 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 182 Neoplasms 115 Prostatic Neoplasms 103 Multiple Myeloma 85 Glioblastoma 82 Pancreatic Neoplasms 76 Glioma 65 Brain Neoplasms 60 Lung Neoplasms 58 Head and Neck Neoplasms 57 Colorectal Neoplasms 55 Melanoma 54 Carcinoma, Non-Small-Cell Lung 53 Leukemia, Myeloid, Acute 51 Carcinoma, Hepatocellular 51 Recurrence 47 Squamous Cell Carcinoma of Head and Neck 46 Ovarian Neoplasms 45 Lymphoma 39 Lymphoma, Non-Hodgkin 37 Lymphoma, B-Cell 36 Sarcoma 35 Stomach Neoplasms 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Neoplasm Metastasis 34 Solid Tumor 31 Hematologic Neoplasms 31 Carcinoma, Renal Cell 30 Polycystic Ovary Syndrome 27 Burkitt Lymphoma 27

Interventions

Indocyanine Green 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Carcinoma, Ductal × Clear all

NCT01796041 2021-01-28

ICG

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed

Carcinoma, Lobular, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡